Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia [Hematologic Malignancy]

Conclusion Patients with cHL who are event free at 2 years have an excellent outcome regardless of baseline prognostic factors. All patients with cHL had an enduring increased risk of death compared with the general population.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Combined Modality Hematologic Malignancy Source Type: research